Gilead Sciences CFO Andrew Dickinson sells $14 million in stock
Andrew Dickinson, the Chief Financial Officer of Gilead Sciences, Inc. (NASDAQ:GILD), recently executed a series of transactions involving the company's stock. On February 12, Dickinson sold 137,676 ...
Live Science on MSN3h
2,000-year-old remains of London's oldest Roman basilica discovered under office building
Remains of a civic basilica give archaeologists clues to what the original layout of Roman London looked like.
pharmaphorum23h
ViiV claims $1.25bn settlement from Gilead in HIV patent dispute
A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved, with Gilead agreeing to pay a $1.25 billion settlement as well as royalties on sales of one of its top HIV products.
bdcmagazine.com14h
Royal London Asset Management Property and Graftongate submit plans for 52-acre scheme in West Midlands
Royal London Asset Management Property, in partnership with Graftongate, has announced plans to develop a prime 52-acre ...